Managing immunosuppression in vasculitis patients in times of COVID-19
Rheumatic diseases clinics of North America
; 2023.
Article
in English
| EuropePMC | ID: covidwho-2279945
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has led to the emergence of multiple challenges in the care of patients with systemic rheumatic diseases. Patients with vasculitis represent a group of particular concern due to existing risk factors which include a higher burden of comorbidities and specific immunosuppressive therapies used for treatment. Vaccination and the use of other risk mitigation strategies are crucial for the care of these patients. This review provides an overview of existing evidence to contribute to the understanding and specific requirements of the treatment and management of patients with vasculitis in the time of COVID-19.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Language:
English
Journal:
Rheumatic diseases clinics of North America
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS